Stock listing
NASDAQ:SNOA Sonoma Pharmaceuticals, Inc. Stock
Home listing (NASDAQ) of Sonoma Pharmaceuticals, Inc.
Follow Sonoma Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:SNOA
$0.722 USD -0.106 (-12.8%)
Close on Nov 20, 2026
- Day range
- $0.722 – $0.840 USDNov 20, 2026
- Volume
- 103,744 sharesNov 20, 2026
- Market cap
- $3.65M USDAt the close on Nov 20, 2026 · price × 5.06M shares outstanding
- 52-week range
- $0.722 – $3.950 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $72,898 USDMedian day 47,300 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SNOA · Home | $0.722 USD | -0.106 (-12.8%) | 103,744 | $0.800 | $0.840 | $0.722 | $0.828 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:SNOA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.722 | -0.106 | -12.8% | $0.800 | $0.840 | $0.722 | 103,744 | |
| $0.828 | -0.006 | -0.8% | $0.851 | $0.853 | $0.797 | 68,845 | |
| $0.834 | -0.046 | -5.2% | $0.880 | $0.880 | $0.830 | 97,324 | |
| $0.880 | -0.210 | -19.2% | $1.070 | $1.100 | $0.800 | 425,193 | |
| $1.090 | -0.080 | -6.8% | $1.200 | $1.200 | $1.080 | 94,745 | |
| $1.170 | -0.070 | -5.6% | $1.260 | $1.270 | $1.150 | 157,742 | |
| $1.240 | +0.100 | +8.8% | $1.260 | $1.299 | $1.180 | 324,217 | |
| $1.140 | +0.010 | +0.9% | $1.091 | $1.170 | $1.091 | 91,339 | |
| $1.130 | +0.020 | +1.8% | $1.170 | $1.190 | $1.102 | 26,682 | |
| $1.110 | +0.040 | +3.7% | $1.100 | $1.148 | $1.080 | 43,572 | |
| $1.070 | -0.040 | -3.6% | $1.130 | $1.145 | $1.070 | 55,268 | |
| $1.110 | -0.030 | -2.6% | $1.130 | $1.160 | $1.105 | 9,966 | |
| $1.140 | +0.040 | +3.6% | $1.090 | $1.160 | $1.080 | 36,662 | |
| $1.100 | 0.000 | 0.0% | $1.080 | $1.150 | $1.050 | 42,242 | |
| $1.100 | -0.100 | -8.3% | $1.160 | $1.170 | $1.070 | 85,814 | |
| $1.200 | +0.060 | +5.3% | $1.184 | $1.200 | $1.162 | 20,237 | |
| $1.140 | -0.010 | -0.9% | $1.140 | $1.180 | $1.119 | 50,626 | |
| $1.150 | +0.030 | +2.7% | $1.100 | $1.160 | $1.100 | 33,670 | |
| $1.120 | +0.010 | +0.9% | $1.120 | $1.200 | $1.100 | 62,801 | |
| $1.110 | -0.040 | -3.5% | $1.130 | $1.130 | $1.110 | 45,900 | |
| $1.150 | +0.010 | +0.9% | $1.130 | $1.170 | $1.120 | 16,900 | |
| $1.140 | -0.010 | -0.9% | $1.170 | $1.190 | $1.120 | 11,800 | |
| $1.150 | +0.030 | +2.7% | $1.160 | $1.170 | $1.130 | 10,600 | |
| $1.120 | 0.000 | 0.0% | $1.110 | $1.150 | $1.100 | 42,600 | |
| $1.120 | -0.030 | -2.6% | $1.230 | $1.230 | $1.120 | 56,900 | |
| $1.150 | -0.010 | -0.9% | $1.150 | $1.210 | $1.120 | 31,300 | |
| $1.160 | -0.020 | -1.7% | $1.160 | $1.180 | $1.130 | 49,100 | |
| $1.180 | -0.050 | -4.1% | $1.250 | $1.250 | $1.170 | 47,700 | |
| $1.230 | 0.000 | 0.0% | $1.240 | $1.290 | $1.220 | 14,800 | |
| $1.230 | +0.070 | +6.0% | $1.170 | $1.260 | $1.160 | 49,300 | |
| $1.160 | -0.060 | -4.9% | $1.200 | $1.200 | $1.140 | 89,000 | |
| $1.220 | -0.010 | -0.8% | $1.230 | $1.230 | $1.200 | 31,600 | |
| $1.230 | +0.010 | +0.8% | $1.270 | $1.270 | $1.210 | 44,700 | |
| $1.220 | -0.020 | -1.6% | $1.240 | $1.250 | $1.220 | 18,600 | |
| $1.240 | -0.010 | -0.8% | $1.280 | $1.290 | $1.220 | 27,400 | |
| $1.250 | -0.030 | -2.3% | $1.310 | $1.310 | $1.250 | 35,300 | |
| $1.280 | +0.030 | +2.4% | $1.240 | $1.300 | $1.200 | 110,700 | |
| $1.250 | -0.010 | -0.8% | $1.270 | $1.280 | $1.240 | 7,600 | |
| $1.260 | -0.010 | -0.8% | $1.290 | $1.290 | $1.240 | 30,400 | |
| $1.270 | +0.020 | +1.6% | $1.240 | $1.290 | $1.240 | 24,300 | |
| $1.250 | 0.000 | 0.0% | $1.240 | $1.290 | $1.200 | 77,700 | |
| $1.250 | -0.050 | -3.8% | $1.310 | $1.310 | $1.250 | 41,500 | |
| $1.300 | +0.050 | +4.0% | $1.270 | $1.300 | $1.260 | 14,400 | |
| $1.250 | -0.030 | -2.3% | $1.280 | $1.280 | $1.250 | 27,600 | |
| $1.280 | +0.020 | +1.6% | $1.260 | $1.340 | $1.240 | 147,400 | |
| $1.260 | +0.030 | +2.4% | $1.240 | $1.270 | $1.240 | 7,700 | |
| $1.230 | -0.050 | -3.9% | $1.280 | $1.280 | $1.230 | 106,100 | |
| $1.280 | -0.010 | -0.8% | $1.300 | $1.300 | $1.270 | 71,100 | |
| $1.290 | -0.020 | -1.5% | $1.300 | $1.300 | $1.280 | 22,100 | |
| $1.310 | 0.000 | 0.0% | $1.340 | $1.340 | $1.290 | 23,000 | |
| $1.310 | +0.010 | +0.8% | $1.300 | $1.310 | $1.290 | 32,200 | |
| $1.300 | -0.030 | -2.3% | $1.330 | $1.340 | $1.300 | 30,700 | |
| $1.330 | 0.000 | 0.0% | $1.350 | $1.360 | $1.310 | 43,500 | |
| $1.330 | +0.010 | +0.8% | $1.300 | $1.330 | $1.280 | 92,800 | |
| $1.320 | +0.030 | +2.3% | $1.300 | $1.320 | $1.290 | 47,300 | |
| $1.290 | 0.000 | 0.0% | $1.300 | $1.310 | $1.290 | 23,400 | |
| $1.290 | 0.000 | 0.0% | $1.280 | $1.310 | $1.260 | 72,500 | |
| $1.290 | -0.020 | -1.5% | $1.280 | $1.310 | $1.270 | 95,800 | |
| $1.310 | -0.020 | -1.5% | $1.330 | $1.370 | $1.280 | 92,400 | |
| $1.330 | -0.050 | -3.6% | $1.400 | $1.400 | $1.330 | 60,300 | |
| $1.380 | +0.030 | +2.2% | $1.340 | $1.410 | $1.340 | 62,400 | |
| $1.350 | +0.010 | +0.7% | $1.360 | $1.360 | $1.320 | 47,341 | |
| $1.340 | 0.000 | 0.0% | $1.330 | $1.350 | $1.320 | 63,406 | |
| $1.340 | 0.000 | 0.0% | $1.330 | $1.360 | $1.320 | 66,600 | |
| $1.340 | -0.020 | -1.5% | $1.370 | $1.380 | $1.310 | 76,000 |
Splits
4 splits since 2013 · NASDAQ:SNOA · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-20 | Consolidation | |
| 1-for-9 | Consolidation | |
| 1-for-5 | Consolidation | |
| 1-for-7 | Consolidation |
- Ticker
- NASDAQ:SNOA
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 10, 2026
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2027 Financial Results, Delivering First-ever Net Income Before Income Tax
Latest deck · January 2026
Investor Presentation (January 2026)
Investor deck · 30 slides
Latest news
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2027 Financial Results, Delivering First-ever Net Income Before Income Tax
Nov 10, 2026
Closed $1.24 (+8.8%) on Nov 11, 2026
Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA
Aug 6, 2026
Closed $1.25 (+10.6%) on Aug 6, 2026
Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution
Jun 30, 2026
Closed $1.23 (0.0%) on Jun 30, 2026
Annual Report for Fiscal Year Ending 03-31, 2026 (Form 10-K)
Jun 16, 2026
Closed $1.15 (+4.5%) on Jun 17, 2026
Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering
Apr 24, 2026
Closed $1.14 (-36.7%) on Apr 24, 2026
Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart
Mar 24, 2026
Closed $2.34 (-8.2%) on Mar 24, 2026
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin
Mar 18, 2026
Closed $2.47 (+2.9%) on Mar 18, 2026
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results
Feb 10, 2026
Closed $2.85 (+1.4%) on Feb 11, 2026
Sonoma Pharmaceuticals, Inc. on 6ix
- News releases
- 10 in the last 12 months · 102 in all · newest Nov 10, 2026 · oldest 2019
- Decks
- 21 decks · latest January 2026
Where Sonoma Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SNOA · Home listing · This page | NASDAQ | United States | USD |
| BOATS:SNOA | BOATS | United States | USD |
| Lang & Schwarz:A40M9J | Lang & Schwarz | Germany | EUR |
| Munich:O8Z | Munich | Germany | EUR |
| Frankfurt:O8Z | Frankfurt | Germany | EUR |
| Stuttgart:O8Z | Stuttgart | Germany | EUR |
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- −$352,530 USD
- P/E
- Loss
- EV/sales
- −0.0×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.6×
- Gross margin
- 39.2%
- Operating margin
- −3.3%
- Net margin
- −7.6%
- Debt to equity
- 0.1×
- Beta vs S&P 500
- 1.53
Forecasts
Analysts' consensus from EODHD, read Nov 12, 2026. Not 6ix's view and not investment advice.
- Price target
- 12.00 USD · Analysts' mean
- EPS, year to Mar 2026
- -1.61 · 1 analyst
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2027 | Nov 10, 2026 | +9.7% |
| Q1 2027 | Aug 6, 2026 | +27.4% |
| Q4 2026 | Jun 16, 2026 | +3.6% |
| Q3 2026 | Feb 10, 2026 · After close | +1.4% |
| Q2 2026 | Nov 4, 2025 · Before open | −0.5% |
| Q1 2026 | Aug 7, 2025 · After close | −1.6% |
| Q4 2025 | Jun 17, 2025 | −7.5% |
| Q3 2025 | Feb 5, 2025 · After close | −0.4% |
| Q2 2025 | Nov 7, 2024 · Before open | +2.1% |
| Q1 2025 | Aug 8, 2024 · After close | −19.4% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2024 | Jun 17, 2024 · After close | +11.8% |
| Q3 2024 | Feb 8, 2024 · After close | 0.0% |
| Q2 2024 | Nov 13, 2023 · After close | 0.0% |
| Q1 2024 | Aug 10, 2023 · After close | −3.0% |
| Q4 2023 | Jun 21, 2023 · After close | +3.5% |
| Q3 2023 | Feb 14, 2023 · After close | +1.3% |
| Q2 2023 | Nov 14, 2022 · After close | +7.2% |
| Q1 2023 | Aug 11, 2022 · After close | −0.9% |
| Q3 2022 | Feb 11, 2022 · After close | −6.9% |
| Quarter to Sep 30, 2021 | Nov 15, 2021 · Before open | −3.1% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (January 2026) | Investor deck | 30 slides | January 2026 |
| Investor Presentation (September 2025) | Investor deck | 30 slides | Sep 29, 2025 |
| Investor Presentation (April 2025) | Investor deck | 31 slides | Apr 28, 2025 |
| Investor Presentation (April 2025) | Investor deck | 31 slides | Apr 7, 2025 |
| Investor Presentation (October 2024) | Investor deck | 33 slides | Oct 22, 2024 |
| Investor Presentation (April 2024) | Investor deck | 32 slides | Apr 9, 2024 |
| Investor Presentation (April 2024) | Investor deck | 32 slides | Apr 2, 2024 |
| Investor Presentation (January 2024) | Investor deck | 28 slides | Jan 10, 2024 |
| Investor Presentation (May 2023) | Investor deck | 23 slides | May 10, 2023 |
| Investor Presentation (January 2023) | Investor deck | 31 slides | Jan 6, 2023 |
All 21 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (January 2022) | Investor deck | 29 slides | Jan 6, 2022 |
| Investor Presentation (March 2021) | Investor deck | 27 slides | Mar 4, 2021 |
| Investor Presentation (January 2021) | Investor deck | 27 slides | Jan 11, 2021 |
| Q2 FY2019 Earnings Presentation | Earnings | 11 slides | Nov 8, 2018 |
| Q1 FY2019 Earnings Presentation | Earnings | 8 slides | Aug 8, 2018 |
| Q4 FY2018 Earnings Presentation | Earnings | 8 slides | Jun 13, 2018 |
| Q3 FY2018 Earnings Presentation | Earnings | 9 slides | Feb 7, 2018 |
| Q2 FY2018 Earnings Presentation | Earnings | 11 slides | Nov 9, 2017 |
| Oculus Innovative Sciences — Dawson James Investor Conference 2015 | Conference | 22 slides | Oct 15, 2015 |
| Oculus Innovative Sciences — Investor Presentation (May 2013) | Investor deck | 27 slides | May 30, 2013 |
| Oculus Innovative Sciences — Corporate Update (June 2012) | Corporate update | 5 slides | Jun 7, 2012 |
Financings
| Raise | Date |
|---|---|
| Public offering of shares of common stock and warrants Announced: about US$4M · US$1.35 a share · Warrants at US$1.35 · Dawson James Securities Dealers: Dawson James Securities (lead) Use of proceeds: General corporate purposes, including working capital | Apr 24, 2026 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Went public as Oculus Innovative Sciences, Inc. Priced at US$8.00 a share on Jan 26, 2007.
- Price
- US$8.00 a share
- Shares offered
- 3,025,000 shares of common stock
- Offering size
- US$24.2 million
- Underwriters
- ROTH CAPITAL PARTNERS, MAXIM GROUP LLC, BROOKSTREET SECURITIES CORPORATION · In the order on the cover
- Shares delivered
- On or about Jan 30, 2007
Steps
| Step | When |
|---|---|
| Filed publicly | Jul 3, 2006 |
| Amended 7 times | Newest Jan 8, 2007 |
| Shares registered with an exchange | Dec 15, 2006 |
| Declared effective by the SEC | Jan 24, 2007 |
| Final prospectus, with the price | Jan 26, 2007 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jan 26, 2007 |
| EFFECT · Notice that a registration is effective | Jan 24, 2007 |
| CORRESP · Letter to the SEC | Jan 22, 2007 |
| FWP · Free writing prospectus | Jan 10, 2007 |
| FWP · Free writing prospectus | Jan 9, 2007 |
| S-1/A · Registration statement, amended | Jan 8, 2007 |
| S-1/A · Registration statement, amended | Jan 3, 2007 |
| CORRESP · Letter to the SEC | Dec 21, 2006 |
| FWP · Free writing prospectus | Dec 21, 2006 |
| CORRESP · Letter to the SEC | Dec 21, 2006 |
All 26 filings
| Filing | Filed |
|---|---|
| CORRESP · Letter to the SEC | Dec 21, 2006 |
| CORRESP · Letter to the SEC | Dec 20, 2006 |
| S-1/A · Registration statement, amended | Dec 20, 2006 |
| CERTNAS · Nasdaq's certificate of listing | Dec 18, 2006 |
| S-1/A · Registration statement, amended | Dec 18, 2006 |
| 8-A12B · Registration of shares for listing on an exchange | Dec 15, 2006 |
| CORRESP · Letter to the SEC | Dec 15, 2006 |
| CORRESP · Letter to the SEC | Dec 15, 2006 |
| UPLOAD · Letter from the SEC | Dec 14, 2006 |
| S-1/A · Registration statement, amended | Dec 1, 2006 |
| UPLOAD · Letter from the SEC | Nov 27, 2006 |
| S-1/A · Registration statement, amended | Nov 13, 2006 |
| UPLOAD · Letter from the SEC | Oct 12, 2006 |
| S-1/A · Registration statement, amended | Sep 18, 2006 |
| UPLOAD · Letter from the SEC | Jul 28, 2006 |
| S-1 · Registration statement | Jul 3, 2006 |
Open IPO · From the cover of the final prospectus (424B4) filed Jan 26, 2007
Financials
Annual, in USD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19.5M | 14.3M | 12.7M | 13.3M | 12.6M | 18.6M | 17.9M | 19.0M | 16.7M | 12.8M |
| Cost of revenue | 12.1M | 8.82M | 7.99M | 8.79M | 8.63M | 12.1M | 9.81M | 10.1M | 9.35M | 7.16M |
| Gross profit | 7.42M | 5.46M | 4.75M | 4.48M | 3.99M | 6.56M | 8.12M | 8.88M | 7.31M | 5.67M |
| Research and development | 2.27M | 1.81M | 1.87M | 207.0K | 125.0K | 555.0K | 1.34M | 1.52M | 1.57M | 1.58M |
| Selling, general and administrative | 7.61M | 7.36M | 7.58M | 8.84M | 9.76M | 9.45M | 14.2M | 18.6M | 19.9M | 17.1M |
| Operating income | -2.46M | -3.71M | -4.70M | -4.57M | -5.89M | -3.45M | -7.39M | -11.3M | -14.2M | -13.0M |
| Depreciation and amortization | 139.0K | 138.0K | 176.0K | 125.0K | 186.0K | 227.0K | 312.0K | 453.0K | 490.0K | 248.0K |
| EBITDA | -2.32M | -3.57M | -4.53M | -4.45M | -5.70M | -3.22M | -7.08M | -10.8M | -13.7M | -12.7M |
| Interest expense | 16.0K | 10.0K | 12.0K | 16.0K | 33.0K | 40.0K | 3.00K | |||
| Income before tax | -3.42M | -2.91M | -5.03M | -5.18M | -5.42M | -3.90M | -3.54M | -11.3M | -14.3M | -12.9M |
| Income tax | -244.0K | 550.0K | -196.0K | -33.0K | -332.0K | 713.0K | 29.0K | 458.0K | 50.0K | -4.27M |
| Net income | -3.17M | -3.46M | -4.83M | -5.15M | -5.09M | -3.95M | -3.31M | -11.8M | -14.3M | 9.27M |
| Earnings per share, basic | -1.89 | -2.79 | -10.63 | -1.52 | -1.92 | -1.97 | -2.24 | -12.77 | -28.49 | 2.20 |
| Earnings per share, diluted | -1.89 | -2.79 | -10.63 | -1.52 | -1.92 | -1.97 | -2.24 | -12.77 | -28.49 | 2.20 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.40M | 5.37M | 3.13M | 3.82M | 7.40M | 4.22M | 3.69M | 3.69M | 10.1M | 17.5M |
| Short-term investments | 0 | 0 | ||||||||
| Receivables | 2.53M | 2.23M | 2.90M | 2.57M | 2.41M | 2.81M | 3.97M | 3.48M | 1.54M | 2.11M |
| Inventory | 3.65M | 2.92M | 2.72M | 2.86M | 2.66M | 2.53M | 2.18M | 3.41M | 2.87M | 2.22M |
| Current assets | 12.1M | 12.6M | 12.5M | 13.8M | 16.4M | 13.0M | 12.3M | 12.5M | 16.3M | 22.6M |
| Property, plant and equipment | 310.0K | 225.0K | 365.0K | 488.0K | 320.0K | 360.0K | 365.0K | 727.0K | 1.14M | 1.24M |
| Goodwill | 0 | 0 | ||||||||
| Total assets | 14.0M | 13.7M | 14.7M | 16.2M | 18.8M | 15.0M | 14.6M | 14.4M | 19.2M | 25.5M |
| Accounts payable | 1.92M | 953.0K | 607.0K | 841.0K | 1.64M | 1.77M | 2.07M | 1.25M | 1.27M | 1.25M |
| Current liabilities | 4.83M | 4.10M | 3.72M | 3.72M | 5.82M | 4.08M | 4.73M | 3.59M | 3.26M | 3.29M |
| Long-term debt | 0 | 1.31M | 0 | 12.0K | 32.0K | 45.0K | ||||
| Total debt | 842.0K | 305.0K | 608.0K | 849.0K | 0 | 1.91M | 481.0K | 334.0K | 262.0K | 172.0K |
| Total liabilities | 10.9M | 9.28M | 8.60M | 8.25M | 10.1M | 9.62M | 8.94M | 3.96M | 3.88M | 4.03M |
| Shareholders' equity | 3.10M | 4.41M | 6.14M | 7.98M | 8.70M | 5.36M | 5.62M | 7.77M | 15.3M | 21.4M |
| Shares outstanding | 1.80M | 1.63M | 780.4K | 4.93M | 3.10M | 2.09M | 1.78M | 1.32M | 685.7K | 4.29M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -3.93M | -88.0K | -2.40M | -6.15M | -4.25M | -3.38M | -4.59M | -11.7M | -12.4M | -8.17M |
| Capital spending | -192.0K | -80.0K | -2.00K | -269.0K | -137.0K | -179.0K | -206.0K | -100.0K | -187.0K | -394.0K |
| Free cash flow | -4.13M | -168.0K | -2.40M | -6.42M | -4.38M | -3.56M | -4.80M | -11.8M | -12.6M | -8.56M |
| Cash from investing | -192.0K | -80.0K | -2.00K | -258.0K | -99.0K | 388.0K | 3.64M | -131.0K | -201.0K | 18.2M |
| Cash from financing | 477.0K | 3.03M | 1.68M | 2.49M | 7.40M | 3.31M | 1.03M | 5.49M | 5.24M | -32.0K |
| Dividends paid | 0 | 0 | ||||||||
| Share buybacks | 0 | -1.00K | 0 | 3.60M | 1.38M | 5.97M | 5.52M | 98.0K | ||
| Change in cash | -2.98M | 2.25M | -692.0K | -3.58M | 3.18M | 529.0K | 2.00K | -6.38M | -7.39M | 9.99M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| S-3 · Registration statement | Nov 13, 2026 | Offer document | SEC |
| 10-Q · Quarterly report | Nov 10, 2026 | Quarterly report | SEC |
| 8-A12B/A · Registration of shares for listing on an exchange, amended | Oct 6, 2026 | Other filings | SEC |
| 8-K · Current report | Oct 6, 2026 | Material contract | SEC |
| 8-K · Current report | Sep 16, 2026 | Meeting outcome | SEC |
| 8-K · Current report | Aug 19, 2026 | Meeting outcome | SEC |
| 10-Q · Quarterly report | Aug 6, 2026 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Jul 28, 2026 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Jul 22, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Jul 9, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Jul 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 9, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Jul 9, 2026 | Offer document | SEC |
| DEFA14A · Additional proxy material | Jun 24, 2026 | Meeting notice | SEC |
| 8-K · Current report | Jun 18, 2026 | Current report | SEC |
| 424B5 · Prospectus | Jun 18, 2026 | Offer document | SEC |
| 10-K · Annual report | Jun 16, 2026 | Annual report | SEC |
| DEF 14A · Proxy statement | May 5, 2026 | Meeting notice | SEC |
| 8-K · Current report | Apr 30, 2026 | Material contract | SEC |
| 424B4 · Prospectus | Apr 27, 2026 | Offer document | SEC |
| PRE 14A · Preliminary proxy statement | Apr 24, 2026 | Meeting notice | SEC |
| EFFECT · Notice that a registration is effective | Apr 24, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | Apr 22, 2026 | Other filings | SEC |
| S-1/A · Registration statement, amended | Apr 22, 2026 | Offer document | SEC |
| CORRESP · Letter to the SEC | Apr 22, 2026 | Other filings | SEC |
| S-1 · Registration statement | Apr 17, 2026 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Apr 10, 2026 | Other filings | SEC |
| DRS · Draft registration statement | Apr 9, 2026 | Offer document | SEC |
| 8-K · Current report | Apr 9, 2026 | Material contract | SEC |
| 10-Q · Quarterly report | Feb 10, 2026 | Quarterly report | SEC |
| 3 · Initial statement of ownership | Feb 9, 2026 | Insider trade | SEC |
| 8-K · Current report | Jan 28, 2026 | Management or board change | SEC |
| 8-K · Current report | Jan 12, 2026 | Current report | SEC |
| 4 · Change in ownership | Jan 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2026 | Insider trade | SEC |
| 8-K · Current report | Jan 2, 2026 | Management or board change | SEC |
| 10-Q · Quarterly report | Nov 4, 2025 | Quarterly report | SEC |
| 8-K · Current report | Oct 23, 2025 | Management or board change | SEC |
| 8-K · Current report | Oct 9, 2025 | Management or board change | SEC |
| 8-K · Current report | Sep 29, 2025 | Current report | SEC |
| 8-K · Current report | Sep 26, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Sep 26, 2025 | Offer document | SEC |
| 8-K · Current report | Aug 29, 2025 | Meeting outcome | SEC |
| 10-Q · Quarterly report | Aug 7, 2025 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Jul 11, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Jun 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 20, 2025 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Jun 17, 2025 | Offer document | SEC |
| 10-K · Annual report | Jun 17, 2025 | Annual report | SEC |
| 8-K · Current report | Apr 28, 2025 | Current report | SEC |
| 8-K · Current report | Apr 7, 2025 | Current report | SEC |
| 8-K · Current report | Mar 25, 2025 | Material contract | SEC |
| 10-Q · Quarterly report | Feb 5, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jan 30, 2025 | Material contract | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 8-K · Current report | Jan 3, 2025 | Management or board change | SEC |
| 144 · Notice of proposed sale | Jan 3, 2025 | Other filings | SEC |
| 144/A · Notice of proposed sale, amended | Jan 3, 2025 | Other filings | SEC |
| 144/A · Notice of proposed sale, amended | Jan 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Jan 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Jan 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Dec 26, 2024 | Other filings | SEC |
| S-8 · Registration statement for employee plans | Dec 20, 2024 | Offer document | SEC |
| 8-K · Current report | Nov 21, 2024 | Current report | SEC |
| 10-Q · Quarterly report | Nov 7, 2024 | Quarterly report | SEC |
| 8-K · Current report | Oct 22, 2024 | Material contract | SEC |
| 8-K · Current report | Sep 20, 2024 | Current report | SEC |
| 424B5 · Prospectus | Sep 20, 2024 | Offer document | SEC |
| 8-K · Current report | Aug 28, 2024 | Meeting outcome | SEC |
| 8-K · Current report | Aug 22, 2024 | Current report | SEC |
| 424B5 · Prospectus | Aug 22, 2024 | Offer document | SEC |
| 8-K · Current report | Aug 21, 2024 | Material contract | SEC |
| DEFA14A · Additional proxy material | Aug 14, 2024 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Aug 14, 2024 | Meeting notice | SEC |
| 10-Q · Quarterly report | Aug 8, 2024 | Quarterly report | SEC |
| DEFA14A · Additional proxy material | Jul 24, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Jul 1, 2024 | Meeting notice | SEC |
| 8-K · Current report | Jun 27, 2024 | Current report | SEC |
| 424B5 · Prospectus | Jun 27, 2024 | Offer document | SEC |
| 4 · Change in ownership | Jun 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 21, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 21, 2024 | Insider trade | SEC |
| PRE 14A · Preliminary proxy statement | Jun 21, 2024 | Meeting notice | SEC |
| S-8 · Registration statement for employee plans | Jun 17, 2024 | Offer document | SEC |
| 10-K · Annual report | Jun 17, 2024 | Annual report | SEC |
| 8-K · Current report | Apr 9, 2024 | Current report | SEC |
| 8-K · Current report | Apr 2, 2024 | Current report | SEC |
| 8-K · Current report | Mar 22, 2024 | Current report | SEC |
| 8-K · Current report | Mar 8, 2024 | Material contract | SEC |
| 424B3 · Prospectus | Mar 8, 2024 | Offer document | SEC |
| 10-Q · Quarterly report | Feb 8, 2024 | Quarterly report | SEC |
| 8-K · Current report | Jan 10, 2024 | Current report | SEC |
| 8-K · Current report | Jan 9, 2024 | Material contract | SEC |
| 4 · Change in ownership | Dec 29, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 29, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 29, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 29, 2023 | Insider trade | SEC |
| 8-K · Current report | Dec 29, 2023 | Management or board change | SEC |
| 8-K · Current report | Dec 15, 2023 | Material contract | SEC |
| 424B3 · Prospectus | Dec 15, 2023 | Offer document | SEC |
| 424B5 · Prospectus | Nov 22, 2023 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Nov 21, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Nov 17, 2023 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 13, 2023 | Quarterly report | SEC |
| UPLOAD · Letter from the SEC | Nov 7, 2023 | Other filings | SEC |
| S-3 · Registration statement | Nov 3, 2023 | Offer document | SEC |
| 424B4 · Prospectus | Oct 30, 2023 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Oct 27, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Oct 24, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Oct 24, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Oct 13, 2023 | Other filings | SEC |
| S-1/A · Registration statement, amended | Oct 13, 2023 | Offer document | SEC |
| 8-K/A · Current report, amended | Oct 11, 2023 | Current report | SEC |
| 8-K · Current report | Oct 11, 2023 | Current report | SEC |
| 8-K · Current report | Sep 28, 2023 | Meeting outcome | SEC |
| UPLOAD · Letter from the SEC | Sep 27, 2023 | Other filings | SEC |
| S-1 · Registration statement | Sep 19, 2023 | Offer document | SEC |
| DEFA14A · Additional proxy material | Sep 14, 2023 | Meeting notice | SEC |
| 10-Q · Quarterly report | Aug 10, 2023 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Jul 27, 2023 | Meeting notice | SEC |
| 3 · Initial statement of ownership | Jul 21, 2023 | Insider trade | SEC |
| 8-K · Current report | Jul 14, 2023 | Management or board change | SEC |
| 4 · Change in ownership | Jul 3, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 3, 2023 | Insider trade | SEC |
| 10-K · Annual report | Jun 21, 2023 | Annual report | SEC |
| 8-K · Current report | May 10, 2023 | Current report | SEC |
| 3 · Initial statement of ownership | Apr 13, 2023 | Insider trade | SEC |
| 8-K · Current report | Apr 13, 2023 | Management or board change | SEC |
| 424B5 · Prospectus | Feb 24, 2023 | Offer document | SEC |
| 8-K · Current report | Feb 24, 2023 | Material contract | SEC |
| 10-Q · Quarterly report | Feb 14, 2023 | Quarterly report | SEC |
| 8-K · Current report | Jan 31, 2023 | Material contract | SEC |
| 8-K · Current report | Jan 6, 2023 | Current report | SEC |
| 4 · Change in ownership | Dec 30, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Dec 30, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Dec 30, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Dec 30, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Dec 30, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Dec 30, 2022 | Insider trade | SEC |
| 8-K · Current report | Dec 30, 2022 | Management or board change | SEC |
| 8-K · Current report | Dec 23, 2022 | Material contract | SEC |
| 424B3 · Prospectus | Dec 23, 2022 | Offer document | SEC |
| 10-Q · Quarterly report | Nov 14, 2022 | Quarterly report | SEC |
| 3 · Initial statement of ownership | Oct 12, 2022 | Insider trade | SEC |
| 8-K · Current report | Oct 7, 2022 | Management or board change | SEC |
| 8-K · Current report | Sep 16, 2022 | Meeting outcome | SEC |
| 10-Q · Quarterly report | Aug 11, 2022 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Jul 22, 2022 | Meeting notice | SEC |
| 8-K · Current report | Jul 22, 2022 | Management or board change | SEC |
| 10-K · Annual report | Jul 13, 2022 | Annual report | SEC |
| NT 10-K · Late filing notice | Jun 29, 2022 | Explanation request | SEC |
| 10-Q · Quarterly report | Feb 11, 2022 | Quarterly report | SEC |
| 8-K · Current report | Jan 20, 2022 | Material contract | SEC |
| 4 · Change in ownership | Jan 14, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jan 14, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jan 14, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jan 14, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jan 14, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jan 14, 2022 | Insider trade | SEC |
| 8-K · Current report | Jan 14, 2022 | Management or board change | SEC |
| S-8 · Registration statement for employee plans | Jan 13, 2022 | Offer document | SEC |
| 8-K · Current report | Jan 6, 2022 | Current report | SEC |
| 10-Q · Quarterly report | Nov 15, 2021 | Quarterly report | SEC |
| 8-K · Current report | Nov 9, 2021 | Material contract | SEC |
| 8-K · Current report | Sep 21, 2021 | Meeting outcome | SEC |
| 8-K · Current report | Sep 3, 2021 | Current report | SEC |
| 424B3 · Prospectus | Sep 3, 2021 | Offer document | SEC |
| DEFA14A · Additional proxy material | Aug 30, 2021 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Aug 23, 2021 | Meeting notice | SEC |
| 10-Q · Quarterly report | Aug 16, 2021 | Quarterly report | SEC |
| DEFA14A · Additional proxy material | Aug 16, 2021 | Meeting notice | SEC |
| 8-K · Current report | Aug 2, 2021 | Management or board change | SEC |
| 8-K · Current report | Jul 30, 2021 | Material contract | SEC |
| 424B3 · Prospectus | Jul 30, 2021 | Offer document | SEC |
| DEF 14A · Proxy statement | Jul 29, 2021 | Meeting notice | SEC |
| 8-K · Current report | Jul 20, 2021 | Current report | SEC |
| 10-K · Annual report | Jul 14, 2021 | Annual report | SEC |
| 8-K · Current report | Jul 9, 2021 | Current report | SEC |
| 8-K · Current report | Jul 6, 2021 | Management or board change | SEC |
| NT 10-K · Late filing notice | Jun 29, 2021 | Explanation request | SEC |
| 8-K · Current report | Mar 31, 2021 | Material contract | SEC |
| 8-K · Current report | Mar 4, 2021 | Current report | SEC |
| 10-Q · Quarterly report | Feb 16, 2021 | Quarterly report | SEC |
| 4 · Change in ownership | Jan 13, 2021 | Insider trade | SEC |
This page holds 200 of 979 filings. Open Filings
Cap table
Built by 6ix from Sonoma Pharmaceuticals, Inc.’s releases · as of Nov 10, 2026
- Common shares
- 5,061,593
- Fully diluted
- 5,061,593
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 5,061,593 | Nov 10, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 10, 2026 | 5,061,593 |
| Sep 30, 2026 | 5,057,755 |
| Sep 30, 2026 | 5,057,755 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Sharon Barbari Other companies: VYNE Therapeutics Inc. (Director · Since at least Jul 19, 2021); Cytokinetics, Incorporated (EVP, Finance & CFO · Mar 1, 2006 – Feb 28, 2017 · Past) | Director · Mar 26, 2014 – Mar 1, 2018 · Past |
| Gregory M French Other companies: Pulmatrix, Inc. (Director · Mar 21, 2014 – Apr 30, 2015 · Past) | Director · Jan 24, 2007 – Dec 18, 2013 · Past |
| Jerome J Dvonch Other companies: NeoGenomics, Inc. (Prinicpal Accounting Officer · May 2, 2011 – May 2, 2011 · Past) | Chief Financial Officer · Since at least Sep 8, 2020 |
| Amy Moss Trombly | Chief Executive Officer · Since at least Sep 27, 2019 |
| Arturo Angel | Senior Vice President of Regulatory, Quality and Product Development · Jan 28, 2026 – Nov 5, 2026 · Past |
| Bruce Thornton | Executive VP and COO · Since at least Jan 7, 2021 |
| Jay E Birnbaum | Director · Since at least Jan 14, 2022 |
| John McLaughlin | Director · Since at least Mar 1, 2013 |
| Philippe Weigerstorfer | Director · Since at least Sep 19, 2018 |
| Robert Allen Northey | Exe. VP of Research and Dev. · Sep 1, 2015 – Jun 29, 2017 · Past |
All 13 people
| Person | Seat |
|---|---|
| Robert Grant Edwards | Chief Financial Officer · Apr 14, 2020 – Apr 23, 2020 · Past |
| Russell Joseph Harrison | Director · Feb 26, 2014 – May 30, 2018 · Past |
| Vanessa Jacoby | Director · Since at least Jan 28, 2026 |
Log in to ask 6ix AI your own questions about Sonoma Pharmaceuticals, Inc.